Try Alerts Free   |   Login
Consumer Staples › Medicinal Chemicals And Botanical Products

CYAN Price Correlated With Financials For Cyanotech

Free historical financial statements for Cyanotech Corp. See how revenue, income, cash flow, and balance sheet financials have changed over 44 quarters since 2011. Compare with CYAN stock chart to see long term trends.

CYAN Stock Compared to Quarterly

CYAN Income Statement

Revenue, Net:8126000
Revenue Per Share:1.3099
Cost of Goods & Services Sold:5232000
Gross Profit:2894000
Selling, General & Admin Expense:1283000
Research & Development Expense:229000
Total Operating Expenses:2529000
Operating Income:365000
Income Taxes:7000
Net Income:278000
Earnings Per Share, Basic:0.04
Shares Outstanding, Basic Avg:6203643

CYAN Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:397000
Change in Accounts Receiveable:-951000
Net Cash from Operations:1035000
Net Cash from Operations Per Share:0.1668
Net Cash from Financing Activities:-219000
Net Cash from Investing Activities:-525000
Net Change in Cash & Equivalents:291000

CYAN Balance Sheet

Cash and Cash Equivalents:2589000
Accounts Receivable, Net:3664000
Total Current Assets:16264000
Property, Plant & Equipment, Net:11885000
Total Assets:32045000
Accounts Payable:2362000
Current Portion of Long-Term Debt:490000
Total Short-Term Liabilities:4821000
Long Term Debt, Non-Current Portion:4336000
Total Liabilities:12558000

Major Holders (from 13F filings)

Investment Type
Value (x$1000)
increase or decrease
Renaissance Technologies LLC
251,909 sh
-5,271 sh
Coastline Trust Co
82,400 sh
Vanguard Group Inc
51,994 sh
Geode Capital Management, LLC
25,490 sh
Heritage Investors Management Corp
13,786 sh
Blackrock Inc.
11,574 sh
Dimensional Fund Advisors LP
10,356 sh
UBS Group Ag
1,838 sh
-3,696 sh
Tower Research Capital LLC (Trc)
933 sh
-2,788 sh
Morgan Stanley
487 sh
165 sh
Advisor Group Holdings, Inc.
0 sh
-2,500 sh
Proequities, Inc.
0 sh

Data imported from Cyanotech Corp SEC filings. Check original filings before making any investment decision.